These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7923878)

  • 21. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
    Pasha RP; Bahrami ZS; Niroomanesh S; Ramzi F; Razavi AR; Shokri F
    Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to Rh D--development and uses.
    Scott ML; Voak D
    Vox Sang; 2000; 78 Suppl 2():79-82. PubMed ID: 10938934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function.
    Armstrong-Fisher SS; Carter MC; Downing I; Fraser RH; Inglis GE; Allan EK; Mackie A; Prowse CV; Templeton JG; Thorpe SJ; Urbaniak SJ
    Transfusion; 1999 Sep; 39(9):1005-12. PubMed ID: 10533828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the characteristics of human monoclonal and polyclonal anti-D as revealed by immunochemical investigations: human monoclonal antibodies share specificities with natural antibodies.
    Thorpe SJ; Bailey SW; Gooi HC; Thompson KM
    Transfus Med; 1992 Jun; 2(2):151-7. PubMed ID: 1284979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of Rh D-positive red cells with monoclonal anti-D.
    Thomson A; Contreras M; Gorick B; Kumpel B; Chapman GE; Lane RS; Teesdale P; Hughes-Jones NC; Mollison PL
    Lancet; 1990 Nov; 336(8724):1147-50. PubMed ID: 1978026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Monoclonal antibodies to Rho(D)-antigen of the Rhesus system. Obtaining the EBV-transformed B-lymphoblastoid human cell lines secreting IgG-anti-D antibodies].
    Deriugina EI; Olovnikova NI; Lemeneva LN; Belkina EV; Udalov GA; Chertkov IL
    Gematol Transfuziol; 1991 Aug; 36(8):11-6. PubMed ID: 1661249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal anti-D for immunoprophylaxis.
    Scott ML
    Vox Sang; 2001 Nov; 81(4):213-8. PubMed ID: 11903995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative functional binding activity of IgG1 and IgG3 anti-D in IgG preparations.
    Gorick BD; Hughes-Jones NC
    Vox Sang; 1991; 61(4):251-4. PubMed ID: 1776242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of human monoclonal IgG antibodies against Rhesus (D) antigen.
    Bron D; Feinberg MB; Teng NN; Kaplan HS
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3214-7. PubMed ID: 6427767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiotypic specificity of a human monoclonal anti-Rhesus(D) antibody.
    Lambin P; Rouger P; Goossens D; Hérance N; de Saint Martin J; Fine JM; Salmon C
    Ann Inst Pasteur Immunol; 1986; 137D(3):383-90. PubMed ID: 3030361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.
    Kumpel BM
    Vox Sang; 2007 Aug; 93(2):99-111. PubMed ID: 17683353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional in vitro studies of recombinant human immunoglobulin G and immunoglobulin A anti-D.
    Nielsen LK; Green TH; Norderhaug L; Sandlie I; Dziegiel MH
    Transfusion; 2007 Feb; 47(2):306-15. PubMed ID: 17302778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human monoclonal anti-D antibodies. I. Their production, serology, quantitation and potential use as blood grouping reagents.
    Kumpel BM; Poole GD; Bradley BA
    Br J Haematol; 1989 Jan; 71(1):125-9. PubMed ID: 2492817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal antibodies against the rhesus D antigen from women with severe Rh immunization submitted to high-dose intravenous immunoglobulin treatment.
    del Aguila C; Guillén MV; de la Cámara C; Llopis R
    Vox Sang; 1994; 66(1):55-60. PubMed ID: 8146984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human lymphoblastoid cell line producing specific antibody against Rh-antigen D.
    Koskimies S
    Scand J Immunol; 1980; 11(1):73-7. PubMed ID: 9537031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies.
    Chapman GE; Ballinger JR; Norton MJ; Parry-Jones DR; Beharry NA; Cousins C; Dash CH; Peters AM
    Clin Exp Immunol; 2007 Oct; 150(1):30-41. PubMed ID: 17680827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.
    Hadley AG; Kumpel BM
    Immunology; 1989 Aug; 67(4):550-2. PubMed ID: 2504663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages.
    Wiener E; Atwal A; Thompson KM; Melamed MD; Gorick B; Hughes-Jones NC
    Immunology; 1987 Nov; 62(3):401-4. PubMed ID: 3117677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional in vivo characterization of human monoclonal anti-D in NOD-scid mice.
    Bazin R; Aubin E; Boyer L; St-Amour I; Roberge C; Lemieux R
    Blood; 2002 Feb; 99(4):1267-72. PubMed ID: 11830475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.